New Zealand markets close in 2 hours 9 minutes

Winner Medical Co., Ltd. (300888.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
30.99-0.51 (-1.62%)
As of 10:36AM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 18.53B
Enterprise value 14.12B
Trailing P/E 48.46
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.41
Price/book (mrq)1.60
Enterprise value/revenue 1.82
Enterprise value/EBITDA 24.37

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 3-25.86%
S&P500 52-week change 326.43%
52-week high 343.86
52-week low 329.25
50-day moving average 334.42
200-day moving average 338.15

Share statistics

Avg vol (3-month) 32.83M
Avg vol (10-day) 34.09M
Shares outstanding 5588.29M
Implied shares outstanding 6588.29M
Float 8144.08M
% held by insiders 179.80%
% held by institutions 13.56%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.9
Forward annual dividend yield 46.03%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 31.59%
5-year average dividend yield 4N/A
Payout ratio 4292.31%
Dividend date 3N/A
Ex-dividend date 402 Jun 2023
Last split factor 21.4:1
Last split date 302 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 4.98%
Operating margin (ttm)9.54%

Management effectiveness

Return on assets (ttm)1.40%
Return on equity (ttm)3.51%

Income statement

Revenue (ttm)7.74B
Revenue per share (ttm)13.07
Quarterly revenue growth (yoy)-18.80%
Gross profit (ttm)N/A
EBITDA 708.55M
Net income avi to common (ttm)385.89M
Diluted EPS (ttm)0.65
Quarterly earnings growth (yoy)-51.60%

Balance sheet

Total cash (mrq)6.28B
Total cash per share (mrq)10.76
Total debt (mrq)1.88B
Total debt/equity (mrq)15.42%
Current ratio (mrq)2.60
Book value per share (mrq)19.82

Cash flow statement

Operating cash flow (ttm)1.12B
Levered free cash flow (ttm)219.23M